求翻译：今年一种名为“Qnexa”的实验性药物显示它能让服用者在大约1年的时间内降低10%的体重。这种药物其实是两种现有药物的配制品，即减肥药物“芬特明”和抗癫痫药物“托吡酯”的混合物。这种混合药剂主要通过两方面入手来对抗肥胖问题，首先其中的芬特明成分是安非他明，即苯丙胺的近似药物，这实际上是一种兴奋剂，尽管其长期使用的潜在副作用尚不明确，但是它的确能抑制人体的饥饿感；而另一方面，托吡酯作为一种对抗医学上对抗癫痫的药物，能够帮助平衡人体大脑内的神经电信号联系，这同样能抑制人的食欲。是什么意思？

正在翻译，请等待...

This year is called the "Qnexa" of the experimental drug show that it can let patients in about 1 years of 10% of the weight reduction. This drug is in fact two of the existing drug of weight loss drugs, that is the "fun" and "anti-epileptic drugs and toxic chemicals ester" mixture. This kind of mix

This year one kind named “Qnexa” the experimental medicine demonstrated it can let taking reduce 10% body weight in about 1 year.This medicine is actually two existing medicines matches the product, namely loses weight the medicine “Fendt to be bright” and the antiepileptic “holds the pyrrole ester”

This year called "Qnexa" experimental drug shows it can take approximately 1 year reducing the weight of 10%. This drug is in fact two kinds of drug preparations, namely, weight-loss drugs "Phentermine" and antiepileptic drugs "TOPAMAX" mixture. This mixed pharmacy main through two aspects start to

正在翻译，请等待...